These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12624151)

  • 41. Fanconi anemia in Ashkenazi Jews.
    Kutler DI; Auerbach AD
    Fam Cancer; 2004; 3(3-4):241-8. PubMed ID: 15516848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Positive selection on the gene RNASEL: correlation between patterns of evolution and function.
    Jin W; Wu DD; Zhang X; Irwin DM; Zhang YP
    Mol Biol Evol; 2012 Oct; 29(10):3161-8. PubMed ID: 22513284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The frequency of mucolipidosis type IV in the Ashkenazi Jewish population and the identification of 3 novel MCOLN1 mutations.
    Bach G; Webb MB; Bargal R; Zeigler M; Ekstein J
    Hum Mutat; 2005 Dec; 26(6):591. PubMed ID: 16287144
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutation screening and association study of the candidate prostate cancer susceptibility genes MSR1, PTEN, and KLF6.
    Bar-Shira A; Matarasso N; Rosner S; Bercovich D; Matzkin H; Orr-Urtreger A
    Prostate; 2006 Jul; 66(10):1052-60. PubMed ID: 16598737
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families.
    Friedrichsen DM; Stanford JL; Isaacs SD; Janer M; Chang BL; Deutsch K; Gillanders E; Kolb S; Wiley KE; Badzioch MD; Zheng SL; Walsh PC; Jarvik GP; Hood L; Trent JM; Isaacs WB; Ostrander EA; Xu J
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1939-44. PubMed ID: 14769943
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of the RNAse L gene in prostate cancer.
    Kieffer N; Schmitz M; Scheiden R; Nathan M; Faber JC
    Bull Soc Sci Med Grand Duche Luxemb; 2006; (1):21-8. PubMed ID: 16869093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.
    Phelan CM; Kwan E; Jack E; Li S; Morgan C; Aubé J; Hanna D; Narod SA
    Hum Mutat; 2002 Nov; 20(5):352-7. PubMed ID: 12402332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [RNASEL study of genetics of prostate cancer and its relation to clinical staging].
    Alvarez-Cubero MJ; Saiz M; Martínez-González LJ; Alvarez JC; Lorente JA; Cozar JM
    Actas Urol Esp; 2012 May; 36(5):306-11. PubMed ID: 22464196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
    Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
    Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of association between RNASEL Arg462Gln variant and the risk of breast cancer.
    Sevinç A; Yannoukakos D; Konstantopoulou I; Manguoglu E; Lüleci G; Colak T; Akyerli C; Colakoglu G; Tez M; Sayek I; Gerassimos V; Nasioulas G; Papadopoulou E; Florentin L; Kontogianni E; Bozkurt B; Kocabas NA; Karakaya AE; Yulug IG; Ozçelik T
    Anticancer Res; 2004; 24(4):2547-9. PubMed ID: 15330212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry.
    Lee AJ; Wang Y; Alcalay RN; Mejia-Santana H; Saunders-Pullman R; Bressman S; Corvol JC; Brice A; Lesage S; Mangone G; Tolosa E; Pont-Sunyer C; Vilas D; Schüle B; Kausar F; Foroud T; Berg D; Brockmann K; Goldwurm S; Siri C; Asselta R; Ruiz-Martinez J; Mondragón E; Marras C; Ghate T; Giladi N; Mirelman A; Marder K;
    Mov Disord; 2017 Oct; 32(10):1432-1438. PubMed ID: 28639421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology.
    Giusti RM; Rutter JL; Duray PH; Freedman LS; Konichezky M; Fisher-Fischbein J; Greene MH; Maslansky B; Fischbein A; Gruber SB; Rennert G; Ronchetti RD; Hewitt SM; Struewing JP; Iscovich J
    J Med Genet; 2003 Oct; 40(10):787-92. PubMed ID: 14569130
    [No Abstract]   [Full Text] [Related]  

  • 53. Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study.
    Krüger S; Silber AS; Engel C; Görgens H; Mangold E; Pagenstecher C; Holinski-Feder E; von Knebel Doeberitz M; Moeslein G; Dietmaier W; Stemmler S; Friedl W; Rüschoff J; Schackert HK;
    Lancet Oncol; 2005 Aug; 6(8):566-72. PubMed ID: 16054567
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutation analysis of an Ashkenazi Jewish family with Gaucher disease in three successive generations.
    Kolodny EH; Firon N; Eyal N; Horowitz M
    Am J Med Genet; 1990 Aug; 36(4):467-72. PubMed ID: 2117855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genome analysis yields mutations linked to hereditary prostate cancer.
    Vastag B
    JAMA; 2002 Feb; 287(7):827-8. PubMed ID: 11851558
    [No Abstract]   [Full Text] [Related]  

  • 56. Hereditary chondrocalcinosis in an Ashkenazi Jewish family.
    Eshel G; Gulik A; Halperin N; Avrahami E; Schumacher HR; McCarty DJ; Caspi D
    Ann Rheum Dis; 1990 Jul; 49(7):528-30. PubMed ID: 2383078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutation analysis suggests role for ribonuclease L gene in prostate cancer.
    Dunn FB
    J Natl Cancer Inst; 2002 Feb; 94(4):244-5. PubMed ID: 11854382
    [No Abstract]   [Full Text] [Related]  

  • 58. Metastatic cancer DNA phenotype identified in normal tissues surrounding metastasizing prostate carcinomas.
    Malins DC; Gilman NK; Green VM; Wheeler TM; Barker EA; Vinson MA; Sayeeduddin M; Hellström KE; Anderson KM
    Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11428-31. PubMed ID: 15280533
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mapping the prostate cell family tree.
    Brewer G
    Nat Rev Cancer; 2024 Feb; 24(2):96. PubMed ID: 38200133
    [No Abstract]   [Full Text] [Related]  

  • 60. Genetic Contributions to Prostate Cancer Disparities in Men of West African Descent.
    Johnson JR; Woods-Burnham L; Hooker SE; Batai K; Kittles RA
    Front Oncol; 2021; 11():770500. PubMed ID: 34820334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.